- Home
- BAK vs AMLX Comparison
BAK vs AMLX Comparison
Compare BAK & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BAK | AMLX |
|---|---|---|
| Founded | 1972 | 2014 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2002 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BAK | AMLX |
|---|---|---|
| Price | $4.40 | $13.99 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $4.40 | ★ $19.56 |
| AVG Volume (30 Days) | ★ 2.7M | 820.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.46 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $380,786,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.40 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1612.94 |
| 52 Week Low | $2.32 | $3.11 |
| 52 Week High | $5.30 | $17.49 |
Technical Indicators
Market Signals| Indicator | BAK | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 56.29 | 46.19 |
| Support Level | $3.37 | $13.28 |
| Resistance Level | $5.30 | $15.41 |
| Average True Range (ATR) | 0.34 | 0.99 |
| MACD | 0.04 | -0.07 |
| Stochastic Oscillator | 51.60 | 16.14 |
Price Performance
Historical ComparisonAbout BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.